Related Experiment Video
Updated: Jan 25, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Medications Associated with Increased Risk of Keratinocyte Carcinoma
Lauren D Crow1, Katherine A Kaizer-Salk1, Hailey M Juszczak1
1Department of Dermatology, University of California San Francisco, 1701 Divisadero Street, Box 0316, San Francisco, CA 94143-0316, USA.
Abstract:
A number of medications for short-term and long-term use have been linked to an increased risk for keratinocyte carcinoma (KC). Immunosuppressive medications are associated with an increased risk for KC and melanoma due to reduction of antitumor immune surveillance, and some immunosuppressive agents directly impact DNA replication and repair. Clinical and epidemiologic studies have shown an increased risk for KC in users of photosensitizing medications. Additional mechanisms include drug-induced modulation of DNA damage repair, enhancement of keratinocyte proliferation, and direct carcinogenic effect. Alternatively, some medications potentially decrease KC risk. This article reviews the literature on medications associated with KC risk.
Insights
Certain medications increase the risk of keratinocyte carcinoma (KC) by affecting immune surveillance and DNA repair. This review examines drugs linked to increased or decreased KC risk.
Area of Science:
- Dermatology
- Pharmacology
- Oncology
Background:
- Medications, both short-term and long-term, are associated with an elevated risk of keratinocyte carcinoma (KC).
- Immunosuppressive drugs can increase KC and melanoma risk by reducing immune surveillance and directly affecting DNA replication and repair.
- Photosensitizing medications have been epidemiologically linked to a higher incidence of KC.
Purpose of the Study:
- To review existing literature on medications associated with an increased risk of keratinocyte carcinoma (KC).
- To explore the mechanisms by which drugs may influence KC development, including immune modulation and DNA damage.
- To identify medications that may potentially decrease KC risk.
Main Methods:
- Literature review of clinical and epidemiologic studies.
- Analysis of proposed mechanisms for drug-induced KC risk.
- Synthesis of findings on medications affecting KC risk.
Main Results:
- Immunosuppressants and photosensitizing agents are linked to increased KC risk.
- Mechanisms include reduced immune surveillance, DNA replication/repair interference, and direct carcinogenicity.
- Some medications may offer a protective effect against KC.
Conclusions:
- Medication use is a significant factor influencing keratinocyte carcinoma risk.
- Understanding these associations is crucial for risk assessment and prevention strategies.
- Further research is needed to elucidate protective medication effects and refine management guidelines.
Related Concept Videos
Relative Risk
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Inhaled Medications
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Endocarditis III: Medical Management

